Should Investors buy ISEC Healthcare?

SINGAPORE - International Specialist Eye Centre (ISEC) is listed in SGX in 2014. The company is at Centrepoint South Mid Valley Kuala Lumpur, Penang Jalan Burma and Lee Hung Ming Eye Centre are centers of excellence in ophthalmology, specifically in clinical care, teaching and research.

The group gives expert therapeutic ophthalmology benefits through its system of four eye focuses in Malaysia, and one in Singapore's Gleneagles Hospital. In 2016, the company extended its administrations to incorporate general restorative administrations through the obtaining of JLM Companies, which contains four facilities in the heartlands of Singapore. 

Notwithstanding its relative youth under people in general eye, ISEC has built a good reputation of both best line and primary concern development, while keeping up a good balance sheet.

Should Investors buy ISEC Healthcare?

Rapid growth of revenue

Since its posting in 2014, ISEC Healthcare's income has expanded by an aggravated yearly rate of 13.9% from S$22.0 million to S$38.1 million. In the meantime, the gathering likewise figured out how to help its profit per share from 0.74 Singapore pennies in 2014 to 1.3 Singapore pennies in 2017. 

The solid development in the two its best line and primary concern was because of a bigger number of patient visits at its current eye focuses. This equity pick is additionally profited by new income commitments from a Malaysian eye focus obtaining, and the previously mentioned general solution facilities. 

The securing of the general prescription facilities adds to the organization's benefits as well as gives another wellspring of patients, and referrals for its eye centers.

Healthy cash position 

As specified before, ISEC human services have a tough asset report. The organization has zero obligation on its books and S$27 million in real money. Over that, the organization produces reliably solid income from its tasks. So this could be a good stock investment. 

Truth be told, its income from tasks have developed at a huge rate of 35% exacerbated, per annum, from just S$2.5 million of every 2014 to S$8.3 million out of 2017. 

Thusly, the gathering is in a decent cash position to seek after extra acquisitions and to pay out profits to shareholders. The organization's reputation for acquisitions additionally demonstrates that the administration isn't hesitant to put resources into growing.

Cheap share price

Shares of ISEC Healthcare Ltd. traded hands at S$0.29 per share. This stock recommendation makes an interpretation of to a price-to-earning proportion of 2.23, an annualized price-to-earnings of 17.7 and a trailing profit yield of 4.1%. 

The way things are, ISEC Healthcare's valuation is less expensive contrasted with other medicinal services organizations, for example, TalkMed Group and Singapore O&G which have a price-to-income proportion of 27 and 18.8 separately. The organization's 4.1% profit yield likewise positions as the third most noteworthy yielding social insurance stock right now.

Final Thought-

ISEC Healthcare has demonstrated some possibility to be a decent speculation and decent stock investment. Other than solid patient development in its current clinics, the company likewise the money related muscle to make acquisitions to extend its system and enhance its item advertising. Likewise, the administration has additionally flagged its expectations to expand its local impression to nations, for example, Vietnam and China. These activities could give assist development impetuses to the company. 

Similarly as vitally, offers of the organization as of now exchange at sensible valuations. Everything considered ISEC Healthcare is unquestionably an upfront investment in my books. 

Hope this article was helpful to you. Keep up to date with our Singapore stock blog for receiving best Singapore stocks investment and stock signals.

Leave a feedback in the comment section. Thank you for reading!

How you will know that stock market is cheap or expensive?

A good investor must know how cheap the stock market is, it can assist us with simplifying our contributing choice. There are two techniques to see whether Singapore stocks market is cheap or expensive?

The main strategy is to contrast the market's present cost with income (PE) proportion to the market's long-haul normal PE proportion. The second strategy is to decide the quantity of net-net stocks in the market. Let’s check it out- 

How you will know that stock market is cheap or expensive?

The main technique 

The nearby securities exchange can be spoken to by the Straits Times Index, or STI for short. It comprises of the 30 greatest stocks in Singapore. Since it is hard to get the past day by day PE proportions of the record, the PE proportions of SPDR STI ETF (SGX: ES3) can be utilized as an intermediary. The SPDR STI ETF is a trade exchanged store (ETF) that reproduces the execution of the STI. Starting at 14 June 2018, the SPDR STI ETF had a PE proportion of 10.8. Here is a portion of the other critical PE proportions that we require: 

1) The long haul normal PE proportion: The STI's normal PE proportion from 1973 to 2010 was 16.9; 

2) An example of a high PE proportion for the STI: Back in 1973, the list's PE proportion hit 35; and 

3) A case of a low PE proportion for the STI: At the beginning of 2009, the record was esteemed at 6 times trailing income. 

In view of the information above, it is practical to state that stocks in Singapore are less expensive than normal at this point. 

The second technique 

In this strategy, we will take a gander at the quantity of net-net stocks accessible in the nearby market. A net-net stock is a stock with a market capitalization that is lower than its net current resource esteem. The net current resource esteem can be figured utilizing the accompanying recipe: 

Net current resource esteem = Total current resources – Total liabilities 

In principle, a net-net stock is a take as financial specialists can get a markdown on the organization's present resources, for example, money, in the wake of peeling off all liabilities. Additionally, the organization's settled resources, for example, properties, are tossed in with the general mish-mash for nothing. Rationale holds that if countless net stocks than common can be found in a securities exchange at one point in time, at that point stocks would liable to be modest right then and there. The accompanying is a graph that demonstrates the net-net stock tally in Singapore since 2005


Right off the bat, the second-50% of 2007 saw the net-net stock tally tumble to a low of beneath 50. This was the point at which the STI achieved a top before the Great Financial Crisis struck. Also, the primary portion of 2009 was the point at which the net-net stock tally hit a high of about 200. It was amid this time the STI achieved its base amid the emergency. We can watch a converse relationship from the graph – when the STI is at a pinnacle, the net-net stock check is low, and when the STI is at a low, the net-net stock tally is high. Starting on 14 June 2018, there were 98 net-net stocks. This is serenely between the net-net stock tally's pinnacle and-trough from 2005 till today.


Hope this content was helpful to you. Keep up to date with our blog for receiving best Singapore stocks recommendations.

Leave a feedback in the comment section. Thank you!!

Hyflux CEO Olivia Lum's letter to stakeholders

SINGAPORE: Singapore water treatment firm Hyflux declared on Tuesday that it is looking for court assurance to rearrange its business and address its obligation heap. The organization, established by gather CEO Olivia Lum, saw its energy business endure maintained shots from the delayed shortcoming in Singapore's power showcase.

Olivia Lum

For Stock Picks Singapore

Sharing the thoughts of MS. Lum's letter, Her thoughts were:-

In the last three decades, Hyflux has grown from a small start-up to a global leader in water infrastructure solutions. Venturing beyond Singapore, we have built landmark projects to deliver clean drinking water to people in China, the Middle East, and Africa.

This would not have been possible without the strong support of our stakeholders. I sincerely thank all shareholders, clients, partners, suppliers, and employees for their belief in us and the valuable roles each of you have played in the Hyflux growth story.

One of our landmark projects is Tuaspring, the first Integrated Water and Power Project in Asia, which is an important track record to boost the group's solution offering to its municipal clients. This innovative project which contributes significantly to our nation's water security, has, in recent years, not escaped the impact of depressed electricity prices in Singapore. As a result, 2017 marked the first full year of losses in our operating history. Although improvements in wholesale electricity prices have reduced losses in the last few months, a sharper rebound in prices is necessary to restore the group to its previous levels of profitability.

Operating in a capital-intensive industry, we have always adopted an asset-light strategy where we divest our completed projects to recycle capital into new investments. These successful divestments have funded our growth through the years. However, our recent plans to divest the Tuaspring project in Singapore and the Tianjin Dagang plant in China have taken longer given the prevailing market and this has added stress to the business.

In view of the challenging environment, our options are to either maintain the status quo and hope to ride out the storm or to step back and assess holistically how to reorganize our liabilities. This will not only protect our viable core businesses but position us for long-term sustainable growth.

We have therefore decided to be proactive, and have appointed Ernst & Young Solutions LLP as our financial advisers and WongPartnership LLP as our legal advisers. Based on their advice, we have commenced a court-supervised liabilities reorganization exercise for certain entities within the group. The main objective of this exercise is to provide much-needed space and time for the group to focus on its ongoing discussions with strategic investors, optimize operations, target areas for growth and complete our projects to keep generating steady cash flow. Through this exercise, we believe that we will emerge stronger and be poised for sustainable growth in the years to come.

On the ground, it will continue to be business as usual.

We remain committed to our clients and key stakeholders, whom we will engage and work closely with throughout this reorganization so as to achieve the best possible outcome in these challenging circumstances.

In the meantime, we have voluntarily suspended trading of our shares and related securities, in the interest of all stakeholder groups.